CompletedNot Applicable

Obstructive Sleep Apnea Syndrome In Patients Treated For Cancer Of The Upper Aerodigestive Tract

France142 participantsStarted 2019-01-21

Plain-language summary

Prospective open-label, non-randomized, monocentric, cohort study, to assess the prevalence and severity of sleep apnea syndrome in patients treated for cancer of the upper aerodigestive tract. The patient follows a usual course of care including, at the end of the treatment of his cancer of the upper aerodigestive tract, screening for obstructive sleep apnea syndrome at 3 months and 6 months (Epworth score and ventilatory polygraphy)

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * macroscopic lesion suggestive of a cancerous tumour of the upper aerodigestive tract (oral cavity, oropharynx, larynx, hypopharynx, cavum, cervical lymph node metastases with an occult primary cancer) * awaiting anatomopathological confirmation Exclusion Criteria: * history of cancer of the upper aerodigestive tract * history of known obstructive sleep apnea syndrome * cancer of the thyroid, salivary glands, nose and paranasal sinuses * patients under guardianship or curatorship

What they're measuring

Occurence of obstructive sleep apnea syndrome

Timeframe: 3 months after the end of treatment for cancer of the upper aerodigestive tract

Trial details

NCT IDNCT04262453

SponsorCentre Hospitalier Sud Francilien

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-09-20

View on ClinicalTrials.gov More Upper Aerodigestive Tract Neoplasms trials